Bellevue Group AG - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 132 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 258.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$1,446,000
+2.0%
300,000
+200.0%
0.02%
-70.5%
Q1 2019$1,417,000
+10.3%
100,000
+5.3%
0.08%
-7.1%
Q4 2018$1,285,000
-39.0%
95,0000.0%0.08%
-37.3%
Q3 2018$2,108,000
+71.2%
95,000
+26.7%
0.13%
+27.6%
Q2 2018$1,231,00075,0000.10%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$102,442,0009.84%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$77,176,0001.36%
Sivik Global Healthcare LLC 600,000$2,856,0000.95%
THB ASSET MANAGEMENT 651,150$3,099,0000.90%
Eversept Partners, LP 886,587$4,220,1540.58%
Spark Investment Management LLC 30,100$143,0000.52%
GLOBEFLEX CAPITAL L P 240,680$1,146,0000.29%
Alambic Investment Management, L.P. 19,493$93,0000.23%
GSA CAPITAL PARTNERS LLP 49,901$238,0000.13%
C M BIDWELL & ASSOCIATES LTD 29,550$141,0000.13%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders